Given that germline SNPs in DCBLD1 are associated with non-smoking lung and head and neck cancers, and demonstrate prognostic value in other cancers, further studies are needed to evaluate its potential as a therapeutic target. Here, DCBLD1 is linked to head and neck cancer.